87 related articles for article (PubMed ID: 16740391)
1. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice.
Rajagopalan G; Kudva YC; Sen MM; Marietta EV; Murali N; Nath K; Moore J; David CS
Cytokine; 2006 Apr; 34(1-2):85-95. PubMed ID: 16740391
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment suppresses IL-17 production by T cell-independent myeloid sources in nonobese diabetic mice.
Gao X; Ding G; Wang Z; Fu H; Ni Z; Ma J; Song S; Liu F; Fu Z
Mol Immunol; 2010 Aug; 47(14):2397-404. PubMed ID: 20554001
[TBL] [Abstract][Full Text] [Related]
4. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N
Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769
[TBL] [Abstract][Full Text] [Related]
5. [Liposome and complete Freund's adjuvant for the prevention of insulitis in non-obese diabetic mice].
Su H; Jiang TJ; Zhou ZG
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):32-4. PubMed ID: 12575229
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
7. [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice].
Wang XX; Niu XH; Zhou ZG
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):105-7. PubMed ID: 12575330
[TBL] [Abstract][Full Text] [Related]
8. Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.
Liddi R; Beales PE; Rosignoli G; Pozzilli P
Horm Metab Res; 2000 Jun; 32(6):201-6. PubMed ID: 10898548
[TBL] [Abstract][Full Text] [Related]
9. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
Lee IF; Qin H; Priatel JJ; Tan R
Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
[TBL] [Abstract][Full Text] [Related]
10. Cytokine regulatory effects on alpha-1 proteinase inhibitor expression in NOD mouse islet endothelial cells.
Papaccio G; Pedullà M; Ammendola E; Todaro M
J Cell Biochem; 2002; 85(1):123-30. PubMed ID: 11891856
[TBL] [Abstract][Full Text] [Related]
11. [Study on the prevention of insulitis and diabetes by complete Freund's adjuvant in NOD female mice].
Yang Z; Wu H; Zhou Z; Liao EY; Yang W
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):411-4. PubMed ID: 12080669
[TBL] [Abstract][Full Text] [Related]
12. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP).
Rivero VE; Cailleau C; Depiante-Depaoli M; Riera CM; Carnaud C
J Autoimmun; 1998 Dec; 11(6):603-10. PubMed ID: 9878082
[TBL] [Abstract][Full Text] [Related]
13. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
[TBL] [Abstract][Full Text] [Related]
14. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse.
Zaccone P; Phillips J; Conget I; Cooke A; Nicoletti F
Clin Immunol; 2005 Apr; 115(1):74-9. PubMed ID: 15870024
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
16. Distinct regulation of autoreactive CD4 T cell expansion by interleukin-4 under conditions of lymphopenia.
Hill NJ; Stotland AB; Sarvetnick NE
J Leukoc Biol; 2007 Mar; 81(3):757-65. PubMed ID: 17164429
[TBL] [Abstract][Full Text] [Related]
17. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
[TBL] [Abstract][Full Text] [Related]
18. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
19. Deregulated stress system in non-obese diabetic lymphocyte.
Liu Z; Aune TM
Genes Immun; 2006 Jul; 7(5):352-8. PubMed ID: 16691184
[TBL] [Abstract][Full Text] [Related]
20. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice.
Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
